Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nadja H, Vissing"'
Autor:
Mahmoud I. Abdel-Aziz, Jonathan Thorsen, Simone Hashimoto, Susanne J H Vijverberg, Anne H Neerincx, Paul Brinkman, Wim van Aalderen, Jakob Stokholm, Morten Arendt Rasmussen, Michael Roggenbuck-Wedemeyer, Nadja H Vissing, Martin Steen Mortensen, Asker Daniel Brejnrod, Louise J Fleming, Clare S Murray, Stephen J Fowler, Urs Frey, Andrew Bush, Florian Singer, Gunilla Hedlin, Björn Nordlund, Dominick E Shaw, Kian Fan Chung, Ian M Adcock, Ratko Djukanovic, Charles Auffray, Aruna T Bansal, Ana R Sousa, Scott S Wagers, Bo Lund Chawes, Klaus Bønnelykke, Søren Johannes Sørensen, Aletta D. Kraneveld, Peter J Sterk, Graham Roberts, Hans Bisgaard, Anke H. Maitland-van der Zee
RATIONALE Children with preschool wheezing or school-age asthma are reported to have airway microbial imbalances. OBJECTIVE To identify clusters in children with asthma or wheezing using oropharyngeal microbiota profiles. METHODS Oropharyngeal swabs,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d64243ce415a15b87534ce62712b5d5
Autor:
Nadja H. Vissing, Mette B. Mønster, Sannie Nordly, Gholamreza K. Dayani, Sofie S. Heedegaard, Jenny D. Knudsen, Ulrikka Nygaard
Publikováno v:
Children, Vol 8, Iss 2, p 126 (2021)
Relapse of neonatal meningitis is most commonly caused by Escherichia coli. Management to prevent relapse varies and evidence is limited. We present four cases of relapsing neonatal E. coli meningitis in Denmark in 2016–2017 and review the current
Externí odkaz:
https://doaj.org/article/ed92a13953b94513a6f8136194f1d81b
Autor:
Bo L K, Chawes, Annalisa, Piccinno, Eskil, Kreiner-Møller, Nadja H, Vissing, Porntiva, Poorisrisak, Li, Mortensen, Erik, Nilson, Amalie, Bisgaard, Anna, Dossing, Maja, Deleuran, Nanna L, Skytt, Nasim, Samandari, Francesco, Sergio, Giorgia, Ciurlia, Gianluigi, Poli, Daniela, Acerbi, Hans, Bisgaard
Publikováno v:
British journal of clinical pharmacology. 75(4)
The fixed combination of beclomethasone (BDP) and formoterol pressurized metered dose inhaler (pMDI) (Foster®, Chiesi Farmaceutici) is being developed in the lower strength (BDP/formoterol: 50/6 μg) to provide an appropriate dosage for children wit